Phenytoin Therapy in a Patient with Recessive Dystrophic Epidermolysis Bullosa

Abstract

Get full access to this article

View all access options for this article.

References

Lockman

Hunninghake

Krivit

Desnick

. Relief of pain of Fabry's disease by diphenylhydantoin. Neurology 1973; 23: 871–5.

Eadie

Tyrer

. Anticonvulsant therapy. Pharmacological basic and practice. 2nd ed. Edinburgh: Churchill Livingstone, 1980.

Bauer

Cooper

Tucker

. Phenytoin therapy of recessive dystrophic epidermolysis bullosa: Clinical trial and proposed mechanism of action on collagenase. N Engl J Med 1980; 303: 776–81.

Eisenberg

Stevens

Schofield

. Epidermolysis bullosa: New therapeutic approaches. Aust J Dermatol 1978; 19: 1–8.

Einsen

. Human skin collagenase: Relationship to the pathogenesis of epidermolysis bullosa dystrophica. J Invest Dermatol 1969; 52: 449–53.

Bauer

Tabas

. A perspective on the role of collagenase in recessive dystrophic epidermolysis bullosa. Arch Dermatol 1969; 124: 734–6.

Cunnane

Kent

McAdoo

. Abnormalities of plasma and erythrocyte essential fatty acid composition in epidermolysis bullosa: Influence of treatment with diphenylhydantoin. J Invest Dermatol 1987; 89: 395–9.

Fine

Johnson

. Efficacy of systemic phenytoin in the treatment of functional epidermolysis bullosa. Arch Dermatol 1988; 124: 1402–6.

Chalmers

RJG

Shuster

. Dominant dystrophic epidermolysis bullosa. Arch Dermatol 1984; 120: 707–8.

10.

Jenkinson

Burrows

Tidman

. Epidermolysis bullosa. Br J Dermatol 1984; 3 (suppl): 73.

11.

Rogers

Yancey

Allen

. Phenytoin therapy for junctional epidermolysis bullosa. Arch Dermatol 1983; 119: 925–6.

12.

Cooper

Bauer

. Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis. Arch Dermatol 1984; 120: 490–5.